https://www.worldpharma.ai/ daily 1 https://www.worldpharma.ai/speakers weekly 0.8 https://www.worldpharma.ai/insights weekly 0.7 https://www.worldpharma.ai/insights/abbvies-dual-il-1-antibody-lutikizumab-meets-phase-3-goal-in-hidradenitis 2026-10-22T16:20:14.645Z monthly 0.6 https://www.worldpharma.ai/insights/roivants-brepocitinib-beats-placebo-in-two-phase-3-uveitis-trials-and-heads-for 2026-10-22T11:22:55.683Z monthly 0.6 https://www.worldpharma.ai/insights/mhra-licenses-arrowheads-quarterly-plozasiran-for-familial-chylomicronaemia 2026-10-22T06:25:04.624Z monthly 0.6 https://www.worldpharma.ai/insights/mhra-withdraws-uk-licence-for-ixchiq-chikungunya-vaccine-after-safety-review 2026-10-21T16:15:16.673Z monthly 0.6 https://www.worldpharma.ai/insights/insilico-hits-first-milestone-in-888m-ai-oncology-discovery-deal-with-servier 2026-10-21T11:16:30.382Z monthly 0.6 https://www.worldpharma.ai/insights/fda-approves-gsks-hibsago-as-first-antisense-drug-for-chronic-hepatitis-b 2026-10-21T06:19:22.715Z monthly 0.6 https://www.worldpharma.ai/insights/amgen-and-astrazenecas-tezspire-holds-eoe-remission-to-one-year-in-phase-3 2026-10-20T16:16:37.219Z monthly 0.6 https://www.worldpharma.ai/insights/disc-medicines-bitopertin-meets-all-phase-3-goals-in-epp-after-fda-rejection-in 2026-10-20T11:19:38.863Z monthly 0.6 https://www.worldpharma.ai/insights/fda-grants-gsks-jemperli-accelerated-approval-in-dmmr-locally-advanced-rectal 2026-10-20T06:17:07.980Z monthly 0.6 https://www.worldpharma.ai/insights/jjs-tremfya-lifts-crohns-fistula-remission-to-35-at-one-year-in-phase-3-fuzion 2026-10-19T16:16:27.524Z monthly 0.6 https://www.worldpharma.ai/insights/nouscom-raises-120m-to-take-lynch-syndrome-cancer-vaccine-into-a-registration 2026-10-19T11:23:29.032Z monthly 0.6 https://www.worldpharma.ai/insights/ema-confirms-refusal-of-omeros-narsoplimab-after-re-examination-in-transplant 2026-10-19T06:16:02.451Z monthly 0.6 https://www.worldpharma.ai/insights/danaher-and-nvidia-move-to-build-ai-models-into-lab-instruments-for-drug 2026-10-18T21:28:30.888Z monthly 0.6 https://www.worldpharma.ai/insights/mhra-licenses-catumaxomab-to-lengthen-the-gap-between-drainages-for-malignant 2026-10-18T16:16:55.145Z monthly 0.6 https://www.worldpharma.ai/insights/china-drafts-ban-on-foreign-takeovers-of-its-cell-and-gene-therapy-and-sirna 2026-10-18T11:14:05.563Z monthly 0.6 https://www.worldpharma.ai/insights/cerevances-non-dopamine-parkinsons-pill-solengepras-meets-phase-3-goal-on-off 2026-10-18T06:15:28.085Z monthly 0.6 https://www.worldpharma.ai/insights/dutch-court-bars-msds-subcutaneous-keytruda-from-eight-european-markets 2026-10-17T16:14:59.073Z monthly 0.6 https://www.worldpharma.ai/insights/fda-launches-rare-disease-framework-to-tailor-evidence-and-manufacturing-reviews 2026-10-17T11:15:23.224Z monthly 0.6 https://www.worldpharma.ai/insights/arrowheads-under-the-skin-rnai-drug-cuts-brain-protein-tau-by-73-in-early-trial 2026-10-17T06:15:31.524Z monthly 0.6 https://www.worldpharma.ai/insights/ema-committee-backs-lillys-oral-glp-1-foundayo-for-eu-obesity-and-diabetes-use 2026-10-16T16:15:24.400Z monthly 0.6 https://www.worldpharma.ai/insights/mhra-adds-boxed-warning-and-patient-card-to-leaflets-for-antidepressants 2026-10-16T11:14:55.819Z monthly 0.6 https://www.worldpharma.ai/insights/osivaxs-nucleoprotein-flu-vaccine-misses-phase-2b-goal-with-24-efficacy-and 2026-10-16T06:20:13.602Z monthly 0.6 https://www.worldpharma.ai/insights/ema-backs-revolution-medicines-rasonque-for-pancreatic-cancer-after-a-sub-150 2026-10-15T16:14:40.558Z monthly 0.6 https://www.worldpharma.ai/insights/biontechs-mrna-immunotherapy-bnt113-misses-progression-goal-in-phase-3-head-and 2026-10-15T11:15:18.151Z monthly 0.6 https://www.worldpharma.ai/insights/fda-extends-immunitybios-anktiva-to-papillary-only-bladder-cancer-without-a-new 2026-10-15T06:15:09.177Z monthly 0.6 https://www.worldpharma.ai/insights/mhra-licenses-lillys-once-weekly-insulin-onswik-meeting-nices-condition-for-nhs 2026-10-14T16:15:31.779Z monthly 0.6 https://www.worldpharma.ai/insights/mhra-2030-strategy-halves-phase-1-trial-review-target-and-plans-ai-protocol 2026-10-14T11:14:58.578Z monthly 0.6 https://www.worldpharma.ai/insights/abbvies-under-the-skin-skyrizi-induction-lifts-crohns-endoscopic-remission-to 2026-10-14T06:15:27.786Z monthly 0.6 https://www.worldpharma.ai/insights/roche-licenses-ronas-alk7-rnai-obesity-candidate-for-up-to-100m-near-term 2026-10-13T16:16:09.706Z monthly 0.6 https://www.worldpharma.ai/insights/viivs-injectable-cabenuva-beats-daily-pills-in-people-with-detectable-hiv-in 2026-10-13T11:15:11.935Z monthly 0.6 https://www.worldpharma.ai/insights/bristol-myers-admilparant-meets-phase-3-ipf-goal-at-60-mg-but-misses-at-120-mg 2026-10-12T16:14:59.476Z monthly 0.6 https://www.worldpharma.ai/insights/forbion-closes-23bn-across-two-funds-the-largest-raise-in-its-history 2026-10-12T11:15:39.706Z monthly 0.6 https://www.worldpharma.ai/insights/fda-clears-roches-tecentriq-after-surgery-for-stage-iii-dmmr-colon-cancer 2026-10-12T06:15:31.658Z monthly 0.6 https://www.worldpharma.ai/insights/vaxcytes-31-strain-pneumococcal-vaccine-matches-pfizer-and-merck-shots-in-phase 2026-10-11T16:15:12.634Z monthly 0.6 https://www.worldpharma.ai/insights/csl-pays-alentis-355-million-upfront-to-co-develop-claudin-1-antibody-lixudebart 2026-10-11T11:15:10.216Z monthly 0.6 https://www.worldpharma.ai/insights/lilly-backed-trex-bio-raises-1167-million-in-nasdaq-ipo-priced-at-14-a-share 2026-10-11T06:15:20.444Z monthly 0.6 https://www.worldpharma.ai/insights/shionogi-agrees-to-buy-intrabio-for-2-billion-to-add-rare-disease-drug-aqneursa 2026-10-10T16:15:25.946Z monthly 0.6 https://www.worldpharma.ai/insights/argenx-halts-phase-3-vyvgart-study-in-sjogrens-disease-after-futility-finding 2026-10-10T11:14:44.614Z monthly 0.6 https://www.worldpharma.ai/insights/gsk-signs-up-for-chai-discoverys-ai-protein-design-models-after-its-own-wet-lab 2026-10-10T06:14:33.042Z monthly 0.6 https://www.worldpharma.ai/insights/viatris-agrees-to-buy-pacira-biosciences-for-165-billion-to-build-its-pain 2026-10-09T16:15:43.466Z monthly 0.6 https://www.worldpharma.ai/insights/sanofi-pays-regeneron-1-billion-upfront-for-four-next-generation-dupixent 2026-10-09T11:15:18.179Z monthly 0.6 https://www.worldpharma.ai/insights/biohub-doe-and-nih-commit-18-billion-to-open-data-for-ai-models-of-cells 2026-10-09T06:15:27.188Z monthly 0.6 https://www.worldpharma.ai/insights/phrma-sues-to-block-medicares-globe-pilot-tying-part-b-rebates-to-19-countries 2026-10-08T16:15:16.149Z monthly 0.6 https://www.worldpharma.ai/insights/novartis-pays-abogen-575-million-upfront-for-mrna-encoded-t-cell-engager-abo2203 2026-10-08T11:15:01.540Z monthly 0.6 https://www.worldpharma.ai/insights/genmab-and-abbvies-epcoritamab-cuts-lymphoma-progression-risk-by-51-in 2026-10-08T05:15:02.856Z monthly 0.6 https://www.worldpharma.ai/insights/nature-biotechnology-analysis-finds-deep-learning-perturbation-models-can-beat 2026-10-07T09:33:32.117Z monthly 0.6 https://www.worldpharma.ai/insights/ai-chatbot-beats-government-leaflet-on-hpv-vaccine-literacy-but-not-on-uptake 2026-10-07T09:34:19.309Z monthly 0.6 https://www.worldpharma.ai/insights/enveda-raises-311-million-series-e-to-push-ai-found-drugs-into-later-trials 2026-10-07T08:36:02.706Z monthly 0.6 https://www.worldpharma.ai/insights/government-accepts-all-44-ai-commission-recommendations-as-mhra-opens-ai 2026-10-06T08:39:41.402Z monthly 0.6 https://www.worldpharma.ai/insights/ai-framework-agent-yields-mrna-vaccines-stable-at-37-c-for-two-months 2026-10-02T13:00:29.890Z monthly 0.6 https://www.worldpharma.ai/insights/ai-designed-drug-for-lung-fibrosis-passes-phase-2a-and-enters-phase-3 2026-09-30T21:57:48.453Z monthly 0.6 https://www.worldpharma.ai/gallery monthly 0.4 https://www.worldpharma.ai/companies weekly 0.7 https://www.worldpharma.ai/contact yearly 0.5 https://www.worldpharma.ai/privacy yearly 0.2 https://www.worldpharma.ai/terms yearly 0.2